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Abstract
Nucleotide excision repair and the ATR-mediated DNA damage checkpoint are two critical 
cellular responses to the genotoxic stress induced by ultraviolet (UV) light and are important for 
cancer prevention. In vivo genetic data indicate that these global responses are coupled. Aziz 
Sancar and colleagues developed an in vitro coupled repair-checkpoint system to analyze the basic 
steps of these DNA damage stress responses in a biochemically defined system. The minimum set 
of factors essential for repair-checkpoint coupling include damaged DNA, the excision repair 
factors (XPA, XPC, XPF-ERCC1, XPG, TFIIH, RPA), the 5′-3′ exonuclease EXO1, and the 
damage checkpoint proteins ATR-ATRIP and TopBP1. This coupled repair-checkpoint system was 
used to demonstrate that the ~30 nucleotide single-stranded DNA (ssDNA) gap generated by 
nucleotide excision repair is enlarged by EXO1 and bound by RPA to generate the signal that 
activates ATR.
Graphical Abstract
Nucleotide excision repair and the ATR-mediated DNA damage checkpoint are two critical 
cellular responses to UV-induced genotoxic stress and are important for cancer prevention. This 
review summarizes the in vitro coupled repair-checkpoint system developed by Aziz Sancar and 
colleagues to analyze the basic steps of these two DNA damage stress responses in a 
biochemically defined reaction. They demonstrated that the ~30 nucleotide single-stranded DNA 
gap generated during the excision repair process by XPA, XPC, XPF-ERCC1, XPG, TFIIH, RPA 
is enlarged by the exonuclease EXO1 and bound by RPA to generate the signal that activates ATR-
ATRIP in the presence of TOPBP1.
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The Sancar lab was a very exciting place to begin a postdoc at the start of the new 
millennium. It was six years after his lab had accomplished the heroic feat of reconstituting 
human nucleotide excision repair in vitro (1), and Aziz had come to the wise decision that 
the DNA excision repair field was “mature” and that his lab would embark upon the newly 
emerging field of DNA damage checkpoints. In fact, DNA damage checkpoints were pretty 
well understood in yeast by this time, in 2001 the Nobel Prize in Medicine was awarded to 
Leland Hartwell for introducing the concept: cell cycle arrest in response to DNA damage to 
ensure repair before cell division (2). However, the human checkpoint genes were just being 
identified, initial Human Genome Project results were published in 2001 (3), and we were 
eager to characterize the proteins encoded by these genes, with the long-term goal of 
reconstituting the human DNA damage checkpoint with purified proteins, and the even-
longer-term goal of coupling nucleotide excision repair and the DNA damage checkpoint in 
vitro. It is our hope that research to understand these two cellular responses to DNA damage 
at a molecular level will ultimately aid in cancer prevention, diagnosis, and treatment.
RECONSTITUTING THE ATR-MEDIATED DNA DAMAGE CHECKPOINT
DNA damage checkpoints are signal transduction pathways induced after DNA damage and 
are composed of proteins in the four conceptual categories of Sensors, Mediators, 
Transducers, and Effectors (4) (Figure 1). The DNA damage checkpoints are broadly 
defined by two types of damage that induce the response: bulky DNA adducts such as those 
generated by ultraviolet (UV) light and double strand breaks such as those introduced by 
ionizing radiation (IR). The DNA damage checkpoints are also defined by the two very large 
sensor kinases, Ataxia Telangiectasia Mutated (ATM) and ATM and Rad3-related (ATR), 
which are activated by the DNA damage caused by IR or UV, respectively. These kinases 
belong to the phosphatidylinositol 3-kinase-related kinase (PIKK) family of Ser/Thr-protein 
kinases which also include DNA-PKcs, SMG1, TRRAP, and mTOR. Upon activation, the 
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sensor kinases ATR and ATM phosphorylate and activate the downstream transducer 
kinases, Chk1 and Chk2, respectively. Considering the historical interest and expertise of the 
Sancar lab in analyzing DNA damage responses to UV light, we chose to focus on the 
ATR→Chk1 pathway, while recognizing that there is considerable crosstalk and overlap 
between these signal transduction pathways.
During the past 16 years we have purified the key human checkpoint proteins in the 
ATR→Chk1 pathway (Figure 2). ATR is a 300 kDa protein that forms a heterodimer with a 
85 kDa protein partner, ATRIP. Initial characterizations of ATR-ATRIP by the Sancar lab 
were performed with epitope-tagged recombinant proteins (5,6), but we later found that 
native ATR-ATRIP purified from HeLa cell extracts (7) was more active and consistent, thus 
we continued to use native protein purified from hundreds of liters of HeLa cells in 
subsequent reconstitution experiments (8–15). During the purification of ATR-ATRIP we 
carefully monitored the ATR-ATRIP-containing fractions for the presence of the other 
PIKKS, especially the highly abundant DNA-PKcs, since these kinases have similar 
sequence specificity (preferring S/TQ) and can phosphorylate the same substrates in vitro 
(16) which complicates data interpretation. Upon activation, ATR phosphorylates itself and 
other key checkpoint proteins. In our reconstituted system, we initially focused on ATR 
phosphorylation of Chk1 (7–14), but have also analyzed phosphorylation of other substrates 
including RPA, p53, and Rad17 (8,13,15) using both quantitative Western blotting with 
phosphospecific antibodies (7–15) and measuring the incorporation of radiolabeled 
phosphate (5,6,10) to analyze the amount of substrate phosphorylation. Chk1 is the ‘classic’ 
ATR substrate, however we analyzed ATR phosphorylation of RPA and p53 in our repair-
checkpoint coupling experiments because Chk1 is expressed at low levels and is not 
phosphorylated during G0/G1 (15,17,18), and therefore not a physiologically relevant 
substrate when studying the coupling of excision repair and ATR activation (discussed more 
below).
My initial project in the Sancar lab was to characterize the human homolog of the fission 
yeast damage sensor Rad17, which has homology to all five subunits of Replication Factor C 
(RFC). We found that hRad17 forms a stable complex with the four small subunits of RFC, 
replacing the large subunit (p140), and we named this checkpoint complex hRad17-RFC 
(19). RFC loads the polymerase processivity clamp, Proliferating Cell Nuclear Antigen, 
PCNA, onto DNA during replication. PCNA is a trimer of identical subunits which share 
homology with the checkpoint proteins Rad9, Rad1, and Hus1, which together form a trimer 
called the checkpoint 9-1-1 complex. We demonstrated by electron microscopy that the 
9-1-1 complex forms a ring-like structure similar to PCNA (20), and that the hRad17-RFC 
complex loads the 9-1-1 complex onto DNA (21). Although these proteins are genetically 
required for the ATR-mediated checkpoint in vivo, the loading reaction is inefficient in vitro, 
and we have not been successful incorporating these checkpoint proteins into our 
reconstituted checkpoint system. We suspect that a component may be missing in our 
system, and indeed, when the 9-1-1-interacting factor RHINO was reported, we re-visited 
the subject with little success (22). Through collaborations with other labs, we also found 
that the 9-1-1 complex interacts with and stimulates several enzymes in the Base Excision 
Repair pathway (23–25) as well as carbamoyl phosphate synthetase/aspartate 
Lindsey-Boltz Page 3





















transcarbamoylase/dihydroorotase (CAD), a multienzymatic protein required for the de novo 
pyrimidine synthesis (26).
A huge advance in the checkpoint field was the 2006 discovery by the William Dunphy lab 
that DNA Topoisomerase 2-Binding Protein 1 (TopBP1) is an activator of ATR-ATRIP (27). 
We had actually purified and tested TopBP1 in our ATR kinase system before this report, but 
had not observed the activator effect due to manganese in our reaction buffer. Early reports 
had indicated that manganese was a requirement for the PIKK class of enzymes (28), and 
thus our ATR kinase system included manganese, but we found that the combination of 
magnesium and manganese inhibits TopBP1 activation of ATR-ATRIP. After eliminating 
manganese, we found TopBP1 to be a potent ATR-ATRIP activator and went on to 
characterize many properties of its ATR-activating activity including its binding and 
stimulation by damaged DNA (7,9) (Figure 3), its cooperative mechanism (8), and its 
binding and stimulation by RPA-coated ssDNA (11).
Long stretches of RPA-coated ssDNA strongly induce the ATR-mediated checkpoint. During 
S phase the long stretches of ssDNA result from the replication fork stalling and helicase 
uncoupling that occurs when polymerases encounter the damage (29). Through direct and 
indirect interactions, RPA recruits key checkpoint proteins to the ssDNA (Figure 4). Direct 
RPA interactions recruit ATR-ATRIP via ATRIP (30) and the TopBP1 activator via its N-
terminus (11). Chk1 is indirectly recruited through interactions with Claspin which interacts 
with Timeless-Tipin via a direct interaction between Tipin and RPA (31). We have found 
that p53 and hRad17 interactions with RPA-coated ssDNA also facilitate their 
phosphorylation by ATR (13). Interactions with RPA-coated ssDNA effectively concentrate 
or crowd the checkpoint proteins together such that ATR is in contact with substrates and 
TopBP1 activator. We have provided evidence for this crowding model both in vitro and in 
vivo by demonstrating ATR activation through tethering key checkpoint proteins to DNA 
using the Lac Repressor-Lac Operon system (12,14,22) as well as with light-induced 
crowding via cryptochrome photobodies (32).
COUPLING NUCLEOTIDE EXCISION REPAIR AND THE ATR-MEDIATED DNA 
DAMAGE CHECKPOINT
It had already been demonstrated in some human cell lines that UV-induced ATR activation 
is dependent on nucleotide excision repair when the cells are in G0 (17,33–35), but two 
advances in 2010 convinced us that our ultimate goal of coupling nucleotide excision repair 
and the DNA damage checkpoint with purified proteins would be attainable: we 
reconstituted ATR activation with RPA-coated ssDNA in vitro (11) and the Muzi-Falconi lab 
reported that the UV-induced ATR checkpoint is activated in G0 when EXO1 converts 
nucleotide excision repair intermediates into long ssDNA gaps in vivo (36,37). After repair 
of UV damage, EXO1 competes with repair synthesis resulting in a small fraction of the ~30 
nucleotide excision repair gaps being resected to generate long stretches of ssDNA. We first 
performed a ‘proof of principle’ experiment to demonstrate in vitro support for this model. 
As shown in Figure 5, in in vitro kinase reactions containing purified ATR-ATRIP, TopBP1, 
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and RPA, we observed RPA phosphorylation only in the presence of ssDNA or when gapped 
DNA was resected by EXO1 (Figure 5).
Although we had now demonstrated EXO1-dependent ATR activation with model DNA 
substrates, it took us much longer to optimize the reaction conditions and to generate 
sufficient quality DNA and excision repair factors to achieve our goal of nucleotide excision 
repair-dependent ATR activation (15). We determined that DNA damaged with the UV-
mimetic N-Acetoxy-2-acetylaminofluorene (AAF) worked better in the reconstitution 
experiments than DNA damaged with UV. AAF induces bulky AAF-guanine adducts in 
DNA which are among the best substrates for nucleotide excision repair, whereas the main 
lesions generated by UV, cyclobutane thymine dimers, are not efficiently excised in in vitro 
reactions (38). We also determined that the amount of DNA damage per plasmid required 
optimization, with ~3 AAFs per plasmid (~1/kb) producing the best results. Less AAF 
damage in the plasmid DNA resulted in less gaps and more AAF damage resulted in more 
gaps yet blocked EXO1 resection, both conditions resulting in a lower ssDNA to dsDNA 
ratio which decreased the signal-to-noise ratio.
EXO1 is a very efficient 5′ to 3′ exonuclease on both gapped and nicked DNA. Therefore, 
any nicks in the DNA generated nonspecifically by any one component resulted in the 
reaction not being dependent on the other components. DNA nicks introduced in the initial 
plasmid preparation, introduced during the AAF damage process, or introduced by nuclease 
contaminants in the repair or checkpoint factors were a problem. This required us to prepare 
very pure excision repair factors: XPA, XPC-HR23B, XPF-ERCC1, XPG, TFIIH, and RPA 
(Figure 6).
Once we obtained good quality DNA and proteins, we were finally able to complete the 
reconstitution experiments. In vitro coupling of nucleotide excision repair and the ATR-
mediated DNA damage checkpoint is shown in Figure 7 (Figure 7). ATR activation, as 
measured by RPA2 phosphorylation, is dependent on the presence of the six excision repair 
factors (RF), TopBP1, EXO1, and AAF-damaged DNA. We also demonstrated repair-
checkpoint coupling as measured by p53 phosphorylation in this study (15).
CONCLUSION
A model summarizing repair-checkpoint coupling is shown in Figure 8 (Figure 8). When 
DNA is damaged by UV or a UV-mimetic agent, the core excision repair factors (XPA, 
XPC-HR23B, XPF-ERCC1, XPG, TFIIH, and RPA) excise the damage, and the resulting 
~30 nucleotide gap is either filled in by polymerases or the gap is enlarged by EXO1. The 
resulting long stretch of ssDNA is coated with RPA which recruits ATR-ATRIP, TopBP1, 
and substrates including p53. This repair-checkpoint coupling work brings together over 25 
years of research in the Sancar lab, and as Aziz so elegantly described in his Nobel 
Biography (39), this work is “the ultimate in reductionist biochemical research that aims to 
explain complex cellular phenomenon in a minimalist in vitro system.” It is our hope that by 
breaking down and rebuilding these repair and checkpoint reactions that we may gain 
sufficient understanding of the molecular mechanisms of these reactions to inform better 
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development of tools for diagnosis, prevention, and treatment of cancer and other human 
disease.
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PIKK phosphoinositol 3-kinase-related kinase
ATM Ataxia Telangiectasia-Mutated
ATR ATM and Rad3-related
PCNA Proliferating Cell Nuclear Antigen
TIM Timeless
TIPIN Timeless interacting protein
CAD carbamoyl phosphate synthetase/aspartate transcarbamoylase/dihydroorotase
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The DNA damage checkpoint pathways. The pathways consist of damage sensors, 
mediators, signal transducers, and effectors. DNA damage by UV and UV-mimetic agents 
activates the ATR→Chk1 pathway. Ionizing Radiation (IR) induces double-strand breaks 
which activates the ATM→Chk2 pathway. Modified from (4).
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Figure 2. Purified Checkpoint Factors
Different subunits in the complexes are indicated with arrows. The checkpoint factors were 
purified as described: ATR-ATRIP (7), Chk1 (9), p53 (8), Rad17-RFC (19), 9-1-1-RHINO 
complex (22), TopBP1 (7), Claspin (40), Timless-Tipin (41), RPA (11).
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Figure 3. TopBP1-dependent stimulation of ATR kinase activity by AAF-damaged DNA
Kinase assays were performed as pictured on the right with ATR–ATRIP, His-Chk1-kd, 
GST-TopBP1-His, and with 0.62–5 nM unmodified (UM) or AAF-damaged (AAF) pUC19 
plasmid DNA. The left shows immunoblotting of the reactions for phosphorylated Chk1 (P-
Chk1, which is phosphorylated at S345) (Upper) and total Chk1 (Lower). The average levels 
of Chk1 phosphorylation from four independent experiments are quantitated in the graph 
below. Reproduced with permission from (7).
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Figure 4. Model of ATR kinase activation by RPA-coated ssDNA
RPA directly interacts with ATRIP, the N-terminus of TopBP1, Tipin (Tip), Rad17, Rad9, 
and p53. The consequence of all of these interactions on long stretches of ssDNA is to 
localize ATR kinase with its TopBP1 activator and substrates. The arrow indicates 
phosphorylation of the checkpoint signal transduction kinase, Chk1, by ATR. In addition to 
Chk1, ATR phosphorylates nearly all of the other proteins depicted, but these 
phosphorylation events are not shown for simplicity.
Lindsey-Boltz Page 13





















Figure 5. Model System for Repair-Checkpoint Coupling
ATR kinase reactions were carried out as depicted on the right with ATR-ATRIP, TopBP1, 
RPA, and EXO1 as indicated. Single-stranded DNA (ssDNA), plasmid DNA (dsDNA), or 
gapped DNA was added to the reaction as indicated. The left shows immunoblotting of the 
reactions for phosphorylated RPA2 (P-RPA2, which is phosphorylated at S33) (Upper) and 
total RPA with antibodies against RPA1 (Lower). Reproduced with permission from (15).
Lindsey-Boltz Page 14





















Figure 6. Purified Nucleotide Excision Repair Factors
Different subunits in the complexes are indicated with arrows. The checkpoint factors were 
purified as described (42).
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Figure 7. Reconstituted Repair-Checkpoint Coupling
Kinase reactions, as diagrammed on the right, contained ATR-ATRIP, TopBP1, RPA, EXO1, 
and different concentrations of unmodified (UM) or AAF DNA from excision reactions with 
or without repair factors (RF) as indicated. Reactions were analyzed by immunoblotting for 
phospho-RPA2 and RPA1 for loading. The graph below shows the relative levels of 
phosphorylated RPA2 from three identical repeats. Reproduced with permission from (15).
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Figure 8. Model of Repair-Checkpoint Coupling
When DNA is damaged by UV, the core excision repair factors excise a ~30 nucleotide 
oligomer containing the damage. The resulting gap is either filled in by polymerases or the 
gap is enlarged by EXO1. The resulting ssDNA is coated with RPA which recruits ATR-
ATRIP, TopBP1, and substrates including p53. Modified from (15).
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